For patients doing well on Osimertinib, the possibility that it might eventually stop working can be a source of anxiety. This is a valid concern — like most targeted cancer therapies, Osimertinib resistance can develop over time. This guide explains why resistance happens, how it is detected, and importantly, what treatment options exist afterward. Understanding […]
Osimertinib Resistance — Causes and What Happens Next Read More »
If you have been researching how to access a medicine like Osimertinib that isn’t available or affordable in your country, you have likely come across the term “Named Patient Medicine.” This guide explains exactly what it means, why it exists, and how it works in practice. What is Named Patient Medicine? Named Patient Medicine (NPM)
Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines Read More »
For patients with EGFR-mutated NSCLC, one of the most worrying possibilities is that the cancer could spread to the brain. Brain metastases occur in a significant proportion of advanced lung cancer patients, and historically, treating cancer that has spread to the brain has been particularly difficult. This is where Osimertinib has made a genuine difference.
Osimertinib and Brain Metastasis — What the Research Shows Read More »
One of the most common questions patients and caregivers ask after a new prescription is simple: why this dose, and not the other one? Osimertinib is available in two strengths — 40 mg and 80 mg — and the choice between them depends on several factors specific to each patient. This guide explains how Osimertinib
Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide) Read More »
Introduction A growing body of scientific evidence continues to reinforce a concerning reality: excess body weight is linked to an increased risk of cancer. A recent global review has expanded our understanding of this relationship, finding that a higher Body Mass Index (BMI) is associated with a greater risk of developing at least 19 different
Higher BMI Raises Risk for 19 Cancers as Global Review Expands the Obesity-Cancer Link Read More »
One of the most common questions we receive at CBMeds is: “Is it legal to get Osimertinib from India?” The answer is yes. This guide explains exactly how it works, what documents you need, and what the process looks like from first inquiry to doorstep delivery. Whether you are a patient, a family member, or
How to Access Osimertinib in India Legally — A Step-by-Step Guide Read More »
Starting a new cancer medicine can feel daunting, especially when you read the long list of possible side effects. This guide gives you a clear, honest picture of what to expect from Osimertinib — what is common, what is rare, what to watch out for, and how to manage side effects so they interfere as
Osimertinib Side Effects — Complete Patient Guide (2026) Read More »
Being told you have EGFR positive lung cancer can feel overwhelming. But here is something important to know from the start: an EGFR mutation in lung cancer is not just a diagnosis — it is a specific piece of information that opens the door to some of the most effective targeted treatments available in oncology
EGFR Positive Lung Cancer — A Complete Guide for Patients and Families Read More »
Introduction Artificial intelligence is rapidly transforming healthcare and biomedical research. From analysing medical images to accelerating drug discovery, AI is helping scientists solve problems that once required years of laboratory work. One of the latest breakthroughs involves AI-designed miniproteins capable of controlling G protein-coupled receptor (GPCR) signaling, a development that could revolutionise modern medicine. GPCRs
If you or a loved one has been diagnosed with EGFR-positive lung cancer, you may have come across two names frequently: Osimertinib and Tagrisso. Many patients wonder whether they are different medicines, whether one is better than the other, and whether it is safe to choose a generic alternative. The short answer is simple: Tagrisso
